Renu Gupta - Net Worth and Insider Trading
Renu Gupta Net Worth
The estimated net worth of Renu Gupta is at least $8,970 dollars as of 2024-11-13. Renu Gupta is the Director of Corbus Pharmaceuticals Holdings Inc and owns about 500 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) stock worth over $8,970. Details can be seen in Renu Gupta's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Renu Gupta has not made any transactions after 2015-08-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Renu Gupta
Renu Gupta Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Renu Gupta owns 3 companies in total, including Corbus Pharmaceuticals Holdings Inc (CRBP) , Insmed Inc (INSM) , and Agenus Inc (AGEN) .
Click here to see the complete history of Renu Gupta’s form 4 insider trades.
Insider Ownership Summary of Renu Gupta
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRBP | Corbus Pharmaceuticals Holdings Inc | 2015-08-18 | director |
| INSM | Insmed Inc | 2013-05-23 | EVP & Chief Medical Officer |
| AGEN | Agenus Inc | 2003-11-03 | Senior VP & Development |
Renu Gupta Latest Holdings Summary
Renu Gupta currently owns a total of 1 stock. Renu Gupta owns 500 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) as of August 18, 2015, with a value of $8,970.
Latest Holdings of Renu Gupta
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRBP | Corbus Pharmaceuticals Holdings Inc | 2015-08-18 | 500 | 17.94 | 8,970 |
Holding Weightings of Renu Gupta
Renu Gupta Form 4 Trading Tracker
According to the SEC Form 4 filings, Renu Gupta has made a total of 0 transactions in Corbus Pharmaceuticals Holdings Inc (CRBP) over the past 5 years. The most-recent trade in Corbus Pharmaceuticals Holdings Inc is the acquisition of 333 shares on August 18, 2015, which cost Renu Gupta around $18,900.
Insider Trading History of Renu Gupta
- 1
Renu Gupta Trading Performance
GuruFocus tracks the stock performance after each of Renu Gupta's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Renu Gupta is -9.68%. GuruFocus also compares Renu Gupta's trading performance to market benchmark return within the same time period. The performance of stocks bought by Renu Gupta within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Renu Gupta's insider trading performs compared to the benchmark.
Performance of Renu Gupta
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.43 | | | | | |
| Relative Return to S&P 500(%) | 27.05 | | | | | |
Renu Gupta Ownership Network
Ownership Network List of Renu Gupta
Ownership Network Relation of Renu Gupta
Renu Gupta Owned Company Details
What does Corbus Pharmaceuticals Holdings Inc do?
Who are the key executives at Corbus Pharmaceuticals Holdings Inc?
Renu Gupta is the director of Corbus Pharmaceuticals Holdings Inc. Other key executives at Corbus Pharmaceuticals Holdings Inc include Chief Financial Officer Sean F. Moran , director & Chief Executive Officer Yuval Cohen , and Chief Commercial Officer Craig Stuart Millian .
Corbus Pharmaceuticals Holdings Inc (CRBP) Insider Trades Summary
Over the past 18 months, Renu Gupta made no insider transaction in Corbus Pharmaceuticals Holdings Inc (CRBP). Other recent insider transactions involving Corbus Pharmaceuticals Holdings Inc (CRBP) include a net purchase of 1,032,632 shares made by Cormorant Global Healthcare Master Fund, Lp , a net purchase of 900,000 shares made by Cormorant Asset Management, Lp , and a net sale of 63,358 shares made by Yuval Cohen .
In summary, during the past 3 months, insiders sold 0 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) in total and bought 350,000 shares, with a net purchase of 350,000 shares. During the past 18 months, 81,401 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) were sold and 1,932,632 shares were bought by its insiders, resulting in a net purchase of 1,851,231 shares.
Corbus Pharmaceuticals Holdings Inc (CRBP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Corbus Pharmaceuticals Holdings Inc Insider Transactions
Renu Gupta Mailing Address
Above is the net worth, insider trading, and ownership report for Renu Gupta. Currently GuruFocus does not have mailing address information for Renu Gupta.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
